Search research articles
Contact Us
Filters
Showing results (221-230 of 269) with videos related to
Page
of 27
Sort By:
Cancer Discovery
|
April 4, 2018
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i>-Rearranged Cancers
Alexander Drilon, Romel Somwar, Biju P Mangatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2026
Molecular lineages of sporadic mismatch-repair deficient colorectal cancer
Michael B Foote, Guilherme Harada, Somer Abdelfattah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
Jacob A Boyer, Ezra Y Rosen, Malvika Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Jason C Chang, Michael Offin, Christina Falcon, et al.
JAMA Oncology
|
November 27, 2024
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies
Michael V Gormally, Monica F Chen, Anne Marie Noronha, et al.
Cancer Discovery
|
June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy
Alexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T Li, Ronglai Shen, Darren Buonocore, et al.
Cancer Discovery
|
December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
Alexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors
Matteo Repetto, Allison L Richards, Monica F Chen, et al.
Cancer Discovery
|
September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations
Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 269) with videos related to
Sort By:
Page
of 27
Cancer Discovery
|
April 4, 2018
Response to ERBB3-Directed Targeted Therapy in <i>NRG1</i>-Rearranged Cancers
Alexander Drilon, Romel Somwar, Biju P Mangatt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 21, 2026
Molecular lineages of sporadic mismatch-repair deficient colorectal cancer
Michael B Foote, Guilherme Harada, Somer Abdelfattah, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 21, 2025
eIF4A controls translation of estrogen receptor alpha and is a therapeutic target in advanced breast cancer
Jacob A Boyer, Ezra Y Rosen, Malvika Sharma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 5, 2021
Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Jason C Chang, Michael Offin, Christina Falcon, et al.
JAMA Oncology
|
November 27, 2024
Next-Generation Sequencing for HLA Genotype Screening and Matching to HLA-Restricted Therapies
Michael V Gormally, Monica F Chen, Anne Marie Noronha, et al.
Cancer Discovery
|
June 3, 2023
SHP2 Inhibition Sensitizes Diverse Oncogene-Addicted Solid Tumors to Re-treatment with Targeted Therapy
Alexander Drilon, Manish R Sharma, Melissa L Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 11, 2018
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial
Bob T Li, Ronglai Shen, Darren Buonocore, et al.
Cancer Discovery
|
December 13, 2022
NVL-520 Is a Selective, TRK-Sparing, and Brain-Penetrant Inhibitor of ROS1 Fusions and Secondary Resistance Mutations
Alexander Drilon, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 24, 2026
The Genomic Landscape of MYC, MYCL, and MYCN Amplified Solid Tumors
Matteo Repetto, Allison L Richards, Monica F Chen, et al.
Cancer Discovery
|
September 13, 2024
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations
Jessica J Lin, Joshua C Horan, Anupong Tangpeerachaikul, et al.
Page
of 27